DNA damage hypersensitivity in cells lacking BRCA2: a review of in vitro and in vivo data

Area of Science:

• Genetics
• Cancer Biology
• DNA Repair

Background:

• BRCA2 (breast-cancer susceptibility gene 2) is a tumor suppressor.
• Cells deficient in BRCA2 exhibit heightened sensitivity to DNA-damaging agents, especially DNA cross-linkers.
• Previous research consistently demonstrated this sensitivity in various cell types.

Purpose of the Study:

• To review findings on BRCA2-deficient cells' sensitivity to DNA damage.
• To discuss these findings in light of new in vivo data from mouse small intestine studies.
• To explore the implications for tumorigenesis in BRCA2 mutation carriers.

Main Methods:

• Literature review of BRCA2 deficiency and DNA damage sensitivity.
• In vivo studies using mouse models of Brca2 deletion in the small intestine.
• Comparative analysis of cellular deletion mechanisms in mice and humans.

Main Results:

• Cells lacking functional BRCA2 are sensitive to DNA cross-linking agents.
• In vivo data from mouse small intestine shows Brca2 deletion is crucial for eliminating cells lacking the protein.
• This cellular deletion mechanism appears essential for preventing tumorigenic clone development in the mouse intestine.

Conclusions:

• The study highlights the critical role of BRCA2 in maintaining genomic stability.
• Efficient cellular deletion of Brca2-deficient cells in the mouse intestine prevents tumor formation.
• This mechanism may be less robust in human mammary glands of BRCA2 mutation carriers, increasing cancer risk.